Coronaviruses genomes are enriched in suboptimal A- and U-ending codons, which are typically associated with reduced translation efficiency due to limited cognate tRNA availability. How coronavirus efficiently express their proteins despite this limitation remains unclear. By analyzing their codon usage, we identify four tRNA modifications-inosine (I), queuosine (Q), 5-methylcarboxymethyluridine/ 5-methylcarboxymethyl-2-thiouridine (mcm(5)U/mcm(5)s(2)U), and 5-methylcytidine/ 5-formylcytidine (m(5)C/f(5)C)-as essential for decoding their suboptimal codons. Notably, SARS-CoV-2 and HCoV-OC43 infections, representing severe and mild human infections, respectively, reprogram these modifications to favor viral protein synthesis. Mechanistically, this reprogramming was driven by altered expression of the corresponding tRNA modifying enzymes. Since both viruses induced DNA damage and oxidative stress-known to similarly alter Q, mcm(5)U/mcm(5)s(2)U, and m(5)C/f(5)C modifications to favor expression of stress response proteins-our findings support that coronavirus genomes have adapted to the tRNA modification landscape under stress conditions. Overall, coronaviruses orchestrate a codon-specific reprogramming of the host tRNA modification landscape, highlighting a conserved strategy that optimizes translation efficiency and represents a promising target for pan-coronavirus antiviral therapy development.
Coronaviruses reprogram the tRNA epitranscriptome to favor viral protein expression.
阅读:4
作者:Muscolino Elena, Puig-Torrents Mireia, Buigues Bisquert Jaime, Correa Mendonca Diogo, Talló-Parra Marc, Perez-Vilaro Gemma, Caño-Prades Omar, Meehan Gavin R, Kerr Karen, Herder Vanessa, Chillón Miguel, Castello Alfredo, Sanjuan Rafael, Patel Arvind H, DÃez Juana
| 期刊: | Nature Communications | 影响因子: | 15.700 |
| 时间: | 2026 | 起止号: | 2026 Feb 19; 17(1):2944 |
| doi: | 10.1038/s41467-026-69700-w | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
